TRANSPLANTATION CANDIDATES WITH HEMATOLOGICAL DISEASES

Clinical trials for TRANSPLANTATION CANDIDATES WITH HEMATOLOGICAL DISEASES explained in plain language.

Never miss a new study

Get alerted when new TRANSPLANTATION CANDIDATES WITH HEMATOLOGICAL DISEASES trials appear

Sign up with your email to follow new studies for TRANSPLANTATION CANDIDATES WITH HEMATOLOGICAL DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New CAR-T therapy aims to remove transplant barriers in blood disease patients

Disease control Not yet recruiting

This early-stage study tests a new treatment using special immune cells (CAR-T cells) designed to target and reduce harmful antibodies that can prevent a successful stem cell transplant. The study involves up to 18 people with blood diseases who have these antibodies. The goal is…

Matched conditions: TRANSPLANTATION CANDIDATES WITH HEMATOLOGICAL DISEASES

Phase: PHASE1, PHASE2 • Sponsor: Chang Yingjun • Aim: Disease control

Last updated May 04, 2026 16:22 UTC

TRANSPLANTATION CANDIDATES WITH HEMATOLOGICAL DISEASES

Get alerted when new TRANSPLANTATION CANDIDATES WITH HEMATOLOGICAL DISEASES trials appear

New CAR-T therapy aims to remove transplant barriers in blood disease patients